Martin James Joseph

Martin James Joseph is listed in filings as Co-CEO and CFO at Cocrystal Pharma, Inc.. This profile follows SEC Form 4 activity through Jan 13, 2026, including 4 public disclosures. Recent filings connect the profile to Cocrystal Pharma, Inc. (COCP). The current snapshot covers public activity from Oct 11, 2024 to Jan 13, 2026. Reported amounts are shown as $54.2K to $5.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.